-
Founded in:
1998-11-06 -
Country:
China -
Address:
Tongji Science and Technology Industrial Park, Jining High-tech Zone -
Tax NO.:
91370800706117999P -
Registered Funds:
452,754,129 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| N-(2)-L-alanyl-L-glutamine |
This product is a component of parenteral nutrition. It can be decomposed into glutamine and alanine in the body. Glutamine can be supplemented through parenteral nutrition infusion. The amino acids released by its decomposition are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.
More
This product is a component of parenteral nutrition. It can be decomposed into glutamine and alanine in the body. Glutamine can be supplemented through parenteral nutrition infusion. The amino acids released by its decomposition are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Paclitaxel |
This product is a new type of anti-microtubule drug that promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy.
More
This product is a new type of anti-microtubule drug that promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy. |
33069-62-4 | 71 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Paclitaxel |
This product is a new type of anti-microtubule drug that promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy.
More
This product is a new type of anti-microtubule drug that promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy. |
33069-62-4 | 71 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Paclitaxel |
This product is a new type of anti-microtubule drug that promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy.
More
This product is a new type of anti-microtubule drug that promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy. |
33069-62-4 | 71 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Xylitol |
It is a nutritional medicine that can supplement calories and improve sugar metabolism. Its metabolism in the body does not rely on the participation of insulin. It directly participates in sugar metabolism through the cell membrane without increasing blood sugar concentration. Its sweetness and heat generation are similar to those of glucose. It can be used as a sugar substitute for diabetic patients. In addition, it has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids. It can be used as a combined drug for diabetes and ketoacidosis during surgical anesthesia.
More
It is a nutritional medicine that can supplement calories and improve sugar metabolism. Its metabolism in the body does not rely on the participation of insulin. It directly participates in sugar metabolism through the cell membrane without increasing blood sugar concentration. Its sweetness and heat generation are similar to those of glucose. It can be used as a sugar substitute for diabetic patients. In addition, it has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids. It can be used as a combined drug for diabetes and ketoacidosis during surgical anesthesia. |
87-99-0 | 15 |